Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
data
life sciences
national blog main
national top stories
new york blog main
new york top stories
praluent
2
×
san francisco blog main
san francisco top stories
adaptive biotechnologies
alicrocumab
american academy of neu
american academy of neurology
amgen
bicycle therapeutics
biogen
biopharma
biotech
board of directors
bostongene
boulder/denver blog main
boulder/denver top stories
canaan partners
cholesterol
contepo
dementia
democrats
detroit blog main
detroit top stories
eisai
fbi raid
fda
fosfomycin
g1 thearpeutics
gene therapy
headache
hiv
What
week
2
×
aces
america
announced
big
bio
biogen
ceo
cholesterol
continues
convoluted
democrats
dreams
drug
flexible
head
headaches
healthcare
holding
inclisiran
insurance
ipo
key
lowering
meant
medco
medicine
medicines
moves
nasdaq
open
passed
previews
pricing
private
public
roundup
scrutiny
spine
suffer
Language
unset
Current search:
praluent
×
week
×
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
4 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
